secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mondelez International, Inc. (MDLZ)
CIK:        0001103982
Form:       8-K
Filed at:   2024-02-02T23:59:59+00:00
Accession:  0001103982-24-000016
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mondelēz appoints Haleon CEO Brian McNamara to Board of Directors
-----------------------------------------------------------------

- Board expanded to 11 members; McNamara appointed effective Feb 1, 2024 as independent director.
- McNamara has been CEO of Haleon plc (formerly GSK Consumer Healthcare) since May 2022.
- He will serve on the People & Compensation and Governance, Membership & Sustainability Committees.
- McNamara receives standard non-employee director compensation per 2023 proxy statement and indemnification.
- No reportable transactions between McNamara and Mondelēz under Item 404(a).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1103982/000110398224000016/0001103982-24-000016-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1103982/000110398224000016/mdlz-20240201.htm
  HTML page:      https://secwatch.observer/filing/0001103982-24-000016

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer